clinical pharmacology adult skin problems slideshow quiz is ringworm contagious gallery of skin problems and image collection clinical pharmacologymechanism of action ecoza topical foam is an azole antifungal see microbiology  pharmacodynamics the pharmacodynamics of ecoza topical foam 1 have not been established pharmacokinetics the systemic absorption of ecoza topical foam 1 following topical application was studied in one clinical trial in adults and one clinical study in pediatric subjects in the adult trial 19 subjects male and female with tinea pedis applied ecoza topical foam 1 once daily for 29 days subjects applied a mean daily amount of 24 g of ecoza topical foam 1 to soles toes interdigital spaces and tops of both feet up to the ankles blood samples were obtained on day 29 at predose and 1 2 4 6 8 and 12 hours after application results mean ± sd showed the time to reach peak plasma concentrations tmax was 68 ± 51 h with maximum concentration cmax of 417 ± 218 pgml the area under the concentration time curve for the first 12 hours post application on day 29 auc 012  was 3440 ± 1920 pghml in the pediatric trial 18 subjects male and female ages 12  17 with interdigital tinea pedis and positive fungal cultures were treated with ecoza topical foam 1 once daily for 4 weeks subjects applied a mean daily amount of 32 g of ecoza topical foam 1 to soles toes interdigital spaces and tops of both feet up to the ankles blood samples were obtained on day 28 at predose and 7 h and 11 h postdose the mean ± sd econazole plasma concentration was 397 ± 289 534 ± 745 and 575 ± 638 pgm l at predose and 7 h and 11 h postdose respectively microbiology mechanism of action econazole nitrate an azole antifungal agent inhibits fungal cytochrome p450mediated 14 alphalanosterol demethylase enzyme this enzyme functions to convert lanosterol to ergosterol the accumulation of 14 alphamethyl sterols correlates with the subsequent loss of ergosterol in the fungal cell wall and may be responsible for the fungistatic activity of econazole mammalian cell demethylation is less sensitive to econazole inhibition activity in vitro and in clinical infections econazole nitrate has been shown to be active against most strains of the following microorganisms both in vitro and in clinical infections see indications and usage  trichophyton rubrum epidermophyton floccosum trichophyton mentagrophytes clinical studies in two multicenter randomized doubleblind vehiclecontrolled clinical trials a total of 505 subjects with interdigital tinea pedis were randomized 11 to ecoza topical foam or vehicle subjects applied the assigned medication once daily for 4 weeks the severity of erythema scaling fissuring maceration vesiculation and pruritus were graded using a 4point scale none mild moderate severe subjects had koh examination and fungal cultures taken to confirm eligibility a total of 339 subjects with positive fungal cultures were evaluated for efficacy efficacy was evaluated on day 43 2 weeks posttreatment with treatment success being defined as complete cure negative koh and fungal culture and no evidence of clinical disease  the study population ranged in age from 12 to 71 years with 3 subjects less than 18 years of age at baseline the subjects were 71 male and 52 caucasian table 1 presents the efficacy results for each trial table 1 efficacy results at two weeks posttreatment day 43 complete cure effective treatment and mycological cure study 1 study 2ecoza topical foam 1 n  82 n  foam vehicle n  83 n  ecoza topical foam 1 n  91 n  foam vehicle n  83 n complete cure 19 232 2 24 23 253 4 48effective treatment† 40 488 9 108 44 484 9 108mycological cure‡ 56 683 13 157 61 670 15 181mycological cure and an absence of clinical signs and symptoms erythema scaling fissuring maceration vesiculation or pruritus †mycological cure and no or mild erythema andor scaling with all other signs and symptoms absent ‡negative koh and fungal culture